• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

TGR-1202 hydrochloride

CAS No. 1532533-78-0

TGR-1202 hydrochloride ( RP5264 hydrochloride | TGR1202 hydrochloride | TGR 1202 hydrochloride )

产品货号. M12156 CAS No. 1532533-78-0

TGR-1202 (RP5264,TGR1202,Umbralisib) 是一种有效的、选择性的、口服的 PI3Kδ 抑制剂,IC50 为 22 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥515 有现货
5MG ¥867 有现货
10MG ¥1720 有现货
100MG ¥7407 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥1378 有现货

生物学信息

  • 产品名称
    TGR-1202 hydrochloride
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    TGR-1202 (RP5264,TGR1202,Umbralisib) 是一种有效的、选择性的、口服的 PI3Kδ 抑制剂,IC50 为 22 nM。
  • 产品描述
    TGR-1202 (RP5264,TGR1202,Umbralisib) is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 22 nM, 50-fold selectivity over PI3Kα/β and >10,000 fold over PI3Kγ; enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest, demonstrates highly synergistic effect with the proteasome inhibitor carfilzomib in lymphoma, leukemia, and myeloma cell lines and primary lymphoma and leukemia cells; synergistically disrupts the 4E-BP1-eIF4F-c-Myc axis with carfilzomib, also potently inhibits 60% of the activity of CK1ε at 1uM.Blood Cancer Phase 3 Clinical
  • 体外实验
    Umbralisib hydrochloride causes a half-maximal inhibition of human whole blood CD19 cell proliferation between 100-300 nM.Umbralisib hydrochloride (10 nM-100 μM) inhibits phosphorylated AKT at Ser473 in a concentration-dependent manner in human lymphoma and leukemia cell lines. Umbralisib hydrochloride (15-50 μM) potently represses the expression of c-Myc in the DLBCL cell line LY7, and is uniquely characterized with structural features suitable for targeting CK1ε in lymphoma cells.
  • 体内实验
    Umbralisib hydrochloride (150 mg/kg, daily p.o.) significantly shrinks the tumors by day 25 in a subcutaneous xenograft model of T-cell acute lymphoblastic leukemia (T-ALL) in NOD/SCID mice using the MOLT-4 cell line.
  • 同义词
    RP5264 hydrochloride | TGR1202 hydrochloride | TGR 1202 hydrochloride
  • 通路
    PI3K/Akt/mTOR signaling
  • 靶点
    PI3K
  • 受体
    PI3K
  • 研究领域
    Cancer
  • 适应症
    Blood cancer

化学信息

  • CAS Number
    1532533-78-0
  • 分子量
    608.0101
  • 分子式
    C31H25ClF3N5O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO
  • SMILES
    CC(C)OC1=C(C=C(C=C1)C2=NN(C3=NC=NC(=C23)N)C(C)C4=C(C(=O)C5=C(O4)C=CC(=C5)F)C6=CC(=CC=C6)F)F.Cl
  • 化学全称
    4H-1-Benzopyran-4-one, 2-[(1S)-1-[4-amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)-, hydrochloride (1:1)

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Locatelli SL, et al. Leukemia. 2016 Dec;30(12):2402-2405. 2. Deng C, et al. Blood. 2017 Jan 5;129(1):88-99. 3. Burris HA 3rd, et al. Lancet Oncol. 2018 Feb 20. pii: S1470-2045(18)30082-2. 4. Lampson BL, et al. Expert Opin Investig Drugs. 2017 Nov;26(11):1267-1279.
产品手册
关联产品
  • Wortmannin

    一种有效的 PI3K 抑制剂,IC50 为 3 nM,不会抑制 PI4K 活性。

  • ETP-46321

    ETP-46321 是一种有效的、选择性的、口服生物可利用的双重 PI3K α/δ 抑制剂,IC50 为 2.3/14.2 nM。

  • Voxtalisib

    一种有效的、高选择性的 I 类 PI3K ATP 竞争性抑制剂。